Alofisel-5003: An Observational Post-Marketing Study on the Effectiveness and Safety of Darvadstrocel in Patients With Crohn's Disease and Complex Perianal Fistulas (INSPIRE)

17/09/2018
19/11/2025
EU PAS number:
EUPAS24267
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Alofisel-5003-clinical-study-protocol-redact1.pdf

English (8.75 MB - PDF) View document
Updated protocol

Alofisel-5003-clinical-study-protocol-redact.pdf

First published: 04/11/2025
English (4.18 MB - PDF) View document
Study results
Study results

Alofisel-5003-clinical-study-report-redact.pdf

English (731.59 KB - PDF) View document
Study report
Other information